Home › Funds › PenderFund Capital Management Ltd. › CDLX

PenderFund Capital Management Ltd. position in CDLX

CARDLYTICS INC · Information Technology

PenderFund Capital Management Ltd. reported holding 53,802,000 shares of CDLX (CARDLYTICS INC) in its Q2 2026 13F filing — a position valued at US$15.5M, representing 2.58% of its reported portfolio and ranking #10 among its reported holdings. PenderFund Capital Management Ltd. has disclosed CDLX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)53.80M sh
Reported value held$15.52M
Portfolio Weight2.58%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PenderFund Capital Management Ltd.'s CDLX position evolved

PenderFund Capital Management Ltd. first disclosed a stake in CDLX in Q1 2024 at 2,000,000 shares (US$2.5M). The position peaked in Q4 2025 at 47,710,000 shares, worth US$19.4M. Across 10 filings, PenderFund Capital Management Ltd. increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 53,802,000 shares valued at US$15.5M — an increase of 6,092,000 shares quarter over quarter.. Notable position changes include a 125% increase in Q2 2024 (shares fell 61% over the following quarter), a 100% increase in Q4 2024 (shares fell 51% over the following quarter), a 511% increase in Q3 2025 (shares fell 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.00M $2.50M New
Q2 2024 4.50M $5.74M Add
Q3 2024 4.50M $5.60M Hold
Q4 2024 9.02M $11.74M Add
Q1 2025 10.02M $254.50K Add
Q2 2025 4.52M $4.40M Reduce
Q3 2025 27.61M $14.68M Add
Q4 2025 47.71M $19.36M Add
Q1 2026 47.71M $13.52M Hold
Q2 2026 53.80M $15.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CDLX and 13F data

CDLX (CARDLYTICS INC) is a Information Technology company. 6 other funds we track also report a position in CDLX — the largest reported positions include CAS Investment Partners, LLC (US$2.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CDLX

All CDLX fund holders →

FAQ

How long has PenderFund Capital Management Ltd. held CDLX?

PenderFund Capital Management Ltd. has disclosed CDLX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is PenderFund Capital Management Ltd.'s current position in CDLX?

As of Q2 2026, PenderFund Capital Management Ltd. holds 53.80M shares of CDLX (CARDLYTICS INC), valued at $15.52M, representing 2.58% of its reported portfolio and ranking #10.

Has PenderFund Capital Management Ltd. been buying or selling CDLX?

In the latest 13F filing (Q2 2026), PenderFund Capital Management Ltd. increased its position in CDLX. The position peaked in Q4 2025 at 47.71M shares.

Which other funds hold CDLX?

Other major institutional holders of CDLX include CAS Investment Partners, LLC, among 6 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.